We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Fiat lux: the dawn of fluorescence in molecular imaging of differentiated thyroid cancer.
- Authors
Verburg, Frederik A.; Keereweer, Stijn
- Abstract
A recent study published in the European Journal of Nuclear Medicine & Molecular Imaging explores the use of fluorescence-based imaging as a potential alternative to radioisotopes in the treatment of differentiated thyroid cancer. The study conducted a phase 1 trial using a fluorescent molecular imaging agent targeted at papillary thyroid cancer (PTC) and found that it was safe and potentially effective in differentiating PTC from healthy thyroid tissue. The combination of molecular imaging and surgery holds promise for identifying multifocal disease and improving patient safety and quality of life. However, further research is needed to optimize the emission wavelength of the tracer and develop a standard for quantification of fluorescence imaging.
- Subjects
THYROID cancer; FLUORESCENCE; RECURRENT laryngeal nerve; THYROID gland; RADIOACTIVE tracers; LARYNGEAL nerves
- Publication
European Journal of Nuclear Medicine & Molecular Imaging, 2024, Vol 51, Issue 8, p2382
- ISSN
1619-7070
- Publication type
Article
- DOI
10.1007/s00259-023-06549-x